Art

J-GLOBAL ID：201902238568390980   Reference number：19A0789239

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

日本における周術期デノスマブの有無による掻tt後の骨の原発性巨細胞腫瘍の臨床転帰:JCOG 1610研究のためのアンケートから【JST・京大機械翻訳】

Author (28)： Urakawa Hiroshi (Department of Orthopaedic Surgery, Nagoya University, Nagoya, Japan) ,  Yonemoto Tsukasa (Division of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan) ,  Matsumoto Seiichi (Department of Orthopaedic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Takagi Tatsuya (Department of Orthopaedic Surgery, Juntendo University, Tokyo, Japan) ,  Asanuma Kunihiro (Department of Orthopaedic Surgery, Graduate School of Medicine, Mie University, Tsu, Japan) ,  Watanuki Munenori (Department of Orthopaedic Surgery, Tohoku University Hospital, Sendai, Japan) ,  Takemoto Akira (Department of Orthopaedic Surgery, School of Medicine, Yokohama City University, Yokohama, Japan) ,  Naka Norifumi (Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan) ,  Matsumoto Yoshihiro (Department of Orthopaedic Surgery, Kyushu University, Fukuoka, Japan) ,  Kawai Akira (Department of Orthopaedic Surgery, National Cancer Center, Tokyo, Japan) ,  Kunisada Toshiyuki (Department of Medical Materials for Musculoskeletal Reconstruction, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan) ,  Kubo Tadahiko (Department of Orthopaedic Surgery, Hiroshima University, Hiroshima, Japan) ,  Emori Makoto (Department of Orthopaedic Surgery, Sapporo Medical University, Sapporo, Japan) ,  Hiraga Hiroaki (Department of Orthopaedic Surgery, Hokkaido Cancer Center, Sapporo, Japan) ,  Hatano Hiroshi (Department of Orthopaedic Surgery, Niigata Cancer Center Hospital, Niigata, Japan) ,  Tsukushi Satoshi (Department of Orthopaedic Surgery, Aichi Cancer Center, Nagoya, Japan) ,  Nishida Yoshihiro (Department of Orthopaedic Surgery, Nagoya University, Nagoya, Japan) ,  Akisue Toshihiro (Department of Orthopaedic Surgery, Kobe University, Kobe, Japan) ,  Morii Takeshi (Department of Orthopaedic Surgery, Kyorin University, Mitaka, Japan) ,  Takahashi Mitsuru (Department of Orthopaedic Surgery, Shizuoka Cancer Center, Shizuoka, Japan) ,  Nagano Akihito (Department of Orthopaedic Surgery, Gifu University, Gifu, Japan) ,  Yoshikawa Hideki (Department of Orthopaedic Surgery, Osaka University, Osaka, Japan) ,  Sato Kenji (Department of Orthopaedic Surgery, Teikyo University, Tokyo, Japan) ,  Kawano Masanori (Department of Orthopaedic Surgery, Oita University, Oita, Japan) ,  Hiraoka Koji (Department of Orthopaedic Surgery, Kurume University, Kurume, Japan) ,  Tanaka Kazuhiro (Department of Endoprosthetic Surgery, Oita University, Oita, Japan) ,  Iwamoto Yukihide (Kyushu Rosai Hospital, Kitakyushu, Japan) ,  Ozaki Toshifumi (Department of Orthopaedic Surgery, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan)
Material： World Journal of Surgical Oncology (Web)
Volume： 16  Issue： 1  Page： 160  Publication year： 2018 
JST Material Number： U7227A  ISSN： 1477-7819  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Giant cell tumor of bone (GCTB...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0789239&from=J-GLOBAL&jstjournalNo=U7227A") }}

Thesaurus term： population(statistics) ,  effectiveness ,  clinical trial ,  *questionnaire ,  therapeutic planning ,  embolization ,  therapy ,  human(primates) ,  subcutaneous administration
Semi thesaurus term： 局所再発 ,  再発率 ,  遠隔再発 ,  *日本臨床腫瘍研究グループ ,  *転帰 ,  *デノスマブ ,  *周術期 , 【Automatic Indexing@JST】

Author keywords (4)： Giant cell tumor of bone ,  Outcome ,  Denosumab ,  Japan

JST classification (2)： Surgical treatment for tumors  (GE03033T) ,  Gene expression  (EC02040Q)

Reference (25)：

• Fletcher CDM. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.
• Oncol Lett; Giant cell tumor of bone arising in long bones possibly originates from the metaphyseal region; N Futamura, H Urakawa, S Tsukushi, E Arai, E Kozawa, N Ishiguro, Y Nishida; 11; 2016; 2629-2634; 10.3892/ol.2016.4264; citation_id=CR2
• J Cancer Res Clin Oncol; Giant cell tumor of bone: treatment and outcome of 214 cases; M Balke, L Schremper, C Gebert, H Ahrens, A Streitbuerger, G Koehler, J Hardes, G Gosheger; 134; 2008; 969-978; 10.1007/s00432-008-0370-x; citation_id=CR3
• J Bone Joint Surg Br; Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?; CL Gaston, R Bhumbra, M Watanuki, AT Abudu, SR Carter, LM Jeys, RM Tillman, RJ Grimer; 93; 2011; 1665-1669; 10.1302/0301-620X.93B12.27663; citation_id=CR4
• J Bone Joint Surg Am; Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers; L van der Heijden, IC van der Geest, HW Schreuder, MA van de Sande, PD Dijkstra; 96; 2014; 10.2106/JBJS.M.00516; citation_id=CR5

Terms in the title (11)： 日本 ,  周術期 ,  デノスマブ ,  TT ,  骨 ,  原発 ,  巨細胞腫瘍 ,  臨床転帰 ,  JCOG ,  研究 ,  アンケート